Cargando…
Does immune checkpoint inhibitor therapy increase the frequency of adverse reactions to concomitant medications?
Autores principales: | Hammond, Sean, Olsson‐Brown, Anna, Grice, Sophie, Naisbitt, Dean J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311166/ https://www.ncbi.nlm.nih.gov/pubmed/35338535 http://dx.doi.org/10.1111/cea.14134 |
Ejemplares similares
-
Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity
por: Hammond, Sean, et al.
Publicado: (2021) -
Questions Submitted for Discussion by Local Societies—Formulated by the Committee Appointed by the American Dental Association
Publicado: (1897) -
Q&A: How does peptide signaling direct plant development?
por: Breiden, Maike, et al.
Publicado: (2016) -
Q&A: How does jasmonate signaling enable plants to adapt and survive?
por: Larrieu, Antoine, et al.
Publicado: (2016) -
Our Unvaccinated Population Steadily Increasing
Publicado: (1921)